Professor of Internal Medicine
Professor of Microbiology and Immunology
Professor of Ecology and Evolutionary Biology
College of Literature, Science, and the Arts
[email protected]
Available to mentor
Adam Lauring, MD, PhD
Professor
Dr. Lauring is a physician-scientist with a research interest in the genetics and evolution of RNA viruses
Lauring Lab
-
MDUniversity of Washington, Seattle, 2002
-
PhDUniversity of Washington, Seattle, 2000
-
BSYale University, New Haven, 1994
Dr. Lauring’s laboratory has worked in three main areas. First, they study the importance of mutation rate and mutational tolerance to the evolution of poliovirus and influenza virus. More recently, they have utilized next generation sequencing of patient samples to define the within-host evolution and transmission of influenza virus, poliovirus, and SARS-CoV-2. Since the beginning of the COVID pandemic, his laboratory has collaborated with large teams to study the genomic epidemiology of respiratory viruses and the effectiveness of vaccines against them.
-
Lauring AS, Martin ET, Eisenberg M, Fitzsimmons WJ, Salzman E, Leis AM, Lyon-Callo S, Bagdasarian N. bioRxiv,PreprintSurveillance of H5 HPAI in Michigan using retail milk
DOI:10.1101/2024.07.04.602115 -
Petrie JG, Moore R, Lauring AS, Kaye KS. Infect Control Hosp Epidemiol, 2024 May; 45 (5): 618 - 629.Journal ArticleIncidence and outcomes of hospital-associated respiratory virus infections by viral species.
DOI:10.1017/ice.2023.263 PMID: 38073596 -
Di H, Pusch EA, Jones J, Kovacs NA, Hassell N, Sheth M, Lynn KS, Keller MW, Wilson MM, Keong LM, Cui D, Park SH, Chau R, Lacek KA, Liddell JD, Kirby MK, Yang G, Johnson M, Thor S, Zanders N, Feng C, Surie D, DeCuir J, Lester SN, Atherton L, Hicks H, Tamin A, Harcourt JL, Coughlin MM, Self WH, Rhoads JP, Gibbs KW, Hager DN, Shapiro NI, Exline MC, Lauring AS, Rambo-Martin B, Paden CR, Kondor RJ, Lee JS, Barnes JR, Thornburg NJ, Zhou B, Wentworth DE, Davis CT. Vaccines (Basel), 2024 May 7; 12 (5):Journal ArticleAntigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves.
DOI:10.3390/vaccines12050505 PMID: 38793756 -
Lewis NM, Zhu Y, Peltan ID, Gaglani M, McNeal T, Ghamande S, Steingrub JS, Shapiro NI, Duggal A, Bender WS, Taghizadeh L, Brown SM, Hager DN, Gong MN, Mohamed A, Exline MC, Khan A, Wilson JG, Qadir N, Chang SY, Ginde AA, Mohr NM, Mallow C, Lauring AS, Johnson NJ, Gibbs KW, Kwon JH, Columbus C, Gottlieb RL, Raver C, Vaughn IA, Ramesh M, Johnson C, Lamerato L, Safdar B, Casey JD, Rice TW, Halasa N, Chappell JD, Grijalva CG, Talbot HK, Baughman A, Womack KN, Swan SA, Harker E, Price A, DeCuir J, Surie D, Ellington S, Self WH, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network . Clin Infect Dis, 2024 Apr 10; 78 (4): 1056 - 1064.Journal ArticleVaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
DOI:10.1093/cid/ciad677 PMID: 38051664 -
Surie D, Yuengling KA, DeCuir J, Zhu Y, Lauring AS, Gaglani M, Ghamande S, Peltan ID, Brown SM, Ginde AA, Martinez A, Mohr NM, Gibbs KW, Hager DN, Ali H, Prekker ME, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Leis AM, Khan A, Hough CL, Bender WS, Duggal A, Bendall EE, Wilson JG, Qadir N, Chang SY, Mallow C, Kwon JH, Exline MC, Shapiro NI, Columbus C, Vaughn IA, Ramesh M, Mosier JM, Safdar B, Casey JD, Talbot HK, Rice TW, Halasa N, Chappell JD, Grijalva CG, Baughman A, Womack KN, Swan SA, Johnson CA, Lwin CT, Lewis NM, Ellington S, McMorrow ML, Martin ET, Self WH, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network . JAMA Netw Open, 2024 Apr 1; 7 (4): e244954Journal ArticleSeverity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults.
DOI:10.1001/jamanetworkopen.2024.4954 PMID: 38573635 -
Raglow Z, Surie D, Chappell JD, Zhu Y, Martin ET, Kwon JH, Frosch AE, Mohamed A, Gilbert J, Bendall EE, Bahr A, Halasa N, Talbot HK, Grijalva CG, Baughman A, Womack KN, Johnson C, Swan SA, Koumans E, McMorrow ML, Harcourt JL, Atherton LJ, Burroughs A, Thornburg NJ, Self WH, Lauring AS, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network . Lancet Microbe, 2024 Mar; 5 (3): e235 - e246.Journal ArticleSARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis.
DOI:10.1016/S2666-5247(23)00336-1 PMID: 38286131 -
DeCuir J, Payne AB, Self WH, Rowley EAK, Dascomb K, DeSilva MB, Irving SA, Grannis SJ, Ong TC, Klein NP, Weber ZA, Reese SE, Ball SW, Barron MA, Naleway AL, Dixon BE, Essien I, Bride D, Natarajan K, Fireman B, Shah AB, Okwuazi E, Wiegand R, Zhu Y, Lauring AS, Martin ET, Gaglani M, Peltan ID, Brown SM, Ginde AA, Mohr NM, Gibbs KW, Hager DN, Prekker M, Mohamed A, Srinivasan V, Steingrub JS, Khan A, Busse LW, Duggal A, Wilson JG, Chang SY, Mallow C, Kwon JH, Exline MC, Columbus C, Vaughn IA, Safdar B, Mosier JM, Harris ES, Casey JD, Chappell JD, Grijalva CG, Swan SA, Johnson C, Lewis NM, Ellington S, Adams K, Tenforde MW, Paden CR, Dawood FS, Fleming-Dutra KE, Surie D, Link-Gelles R, CDC COVID-19 Vaccine Effectiveness Collaborators . MMWR Morb Mortal Wkly Rep, 2024 Feb 29; 73 (8): 180 - 188.Journal ArticleInterim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024.
DOI:10.15585/mmwr.mm7308a5 PMID: 38421945 -
Frutos AM, Price AM, Harker E, Reeves EL, Ahmad HM, Murugan V, Martin ET, House S, Saade EA, Zimmerman RK, Gaglani M, Wernli KJ, Walter EB, Michaels MG, Staat MA, Weinberg GA, Selvarangan R, Boom JA, Klein EJ, Halasa NB, Ginde AA, Gibbs KW, Zhu Y, Self WH, Tartof SY, Klein NP, Dascomb K, DeSilva MB, Weber ZA, Yang D-H, Ball SW, Surie D, DeCuir J, Dawood FS, Moline HL, Toepfer AP, Clopper BR, Link-Gelles R, Payne AB, Chung JR, Flannery B, Lewis NM, Olson SM, Adams K, Tenforde MW, Garg S, Grohskopf LA, Reed C, Ellington S, CDC Influenza Vaccine Effectiveness Collaborators . MMWR Morb Mortal Wkly Rep, 2024 Feb 29; 73 (8): 168 - 174.Journal ArticleInterim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
DOI:10.15585/mmwr.mm7308a3 PMID: 38421935
News Release
A new NIH award will establish the Michigan Infectious Disease Genomics (MIDGE) Center, the goal of which is to use whole genome sequencing and functional genomic assays to determine how genetic differences among strains or isolates affect the behavior, transmission, and drug resistance of viral, bacterial, and fungal pathogens.
Department News
The Department of Microbiology and Immunology (M&I) celebrated 25 years of its NIH T32 training grant that supports the Molecular Mechanisms in Microbial Pathogenesis Training Program (MMMP) with a scientific symposium, held June 18, 2024.
Medical School News
Many Michigan Medicine labs are taking time to ensure that they are doing their part to support the Medical School’s major initiatives, including the push for carbon neutrality.
